- Generic name
- Esomeprazole
- Strength
- 20 mg
- Dosage form
- Capsule
- Manufactured by
- Indo-Bangla Pharmaceuticals Ltd.
Indonix 20 Capsule
About Indonix 20 Capsule
Indonix 20 20 mg is a capsule product of Indo-Bangla Pharmaceuticals Ltd. that contains Esomeprazole. It helps heal erosive esophagitis and maintain healing after healing has occurred.
There are 161 brands of Esomeprazole listed in Bangladesh. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Indonix 20 Capsule?
Indonix 20 20 mg capsule is a medicine made by Indo-Bangla Pharmaceuticals Ltd. Its active ingredient is Indonix 20razole, a proton pump inhibitor. Doctors prescribe it for long-standing heartburn and other symptoms of gastro-oesophageal reflux disease, for healing and keeping healed erosive oesophagitis, and as part of a combination treatment to clear Helicobacter pylori infection in people with duodenal ulcer disease. Do not change the dose yourself.
Uses of Indonix 20
It helps heal erosive esophagitis and maintain healing after healing has occurred. In some patients with duodenal ulcer disease it is prescribed alongside other antibiotics to clear Helicobacter pylori infection. Indonix 20 20 mg capsule is used for acid-related stomach and food-pipe problems. Your doctor will confirm whether it suits your condition.
How to use Indonix 20
Swallow the capsule with water. Indonix 20 is taken by mouth. You can take it with or without food. The doctor decides the dose and course.
Side effects of Indonix 20
Your doctor can advise on what to watch for in your own case. The most common ones reported are headache, diarrhoea, nausea, wind, stomach pain, constipation and dry mouth. Serious side effects are uncommon; seek medical help if you notice any unusual or severe symptoms. Ask your doctor or pharmacist about anything you notice while taking Indonix 20. Tell your doctor or pharmacist if any side effect bothers you or does not settle.
Safety and precautions
Do not take Indonix 20 if you have had an allergic reaction to Esomeprazole or to any ingredient of the capsule. A good response to treatment does not rule out a serious stomach problem, so your doctor may want to check further. It is not known if Esomeprazole passes into breast milk, so breastfeeding may need to be stopped if this medicine is essential. Ask your doctor before use if you are pregnant, planning pregnancy or breastfeeding, and keep the medicine out of children's reach.
Frequently asked questions
Why is Indonix 20 prescribed?
It helps heal erosive esophagitis and maintain healing after healing has occurred. In some patients with duodenal ulcer disease it is prescribed alongside other antibiotics to clear Helicobacter pylori infection.
How is Indonix 20 used?
Swallow the capsule with water. Indonix 20 is taken by mouth.
Can Indonix 20 cause side effects?
Your doctor can advise on what to watch for in your own case. The most common ones reported are headache, diarrhoea, nausea, wind, stomach pain, constipation and dry mouth.
Who should be careful with Indonix 20?
Do not take Indonix 20 if you have had an allergic reaction to Esomeprazole or to any ingredient of the capsule. A good response to treatment does not rule out a serious stomach problem, so your doctor may want to check further.
Indications
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease. ... Read more
- To relieve from chronic heartburn symptoms and other symptoms associated with GERD
- For the healing of erosive esophagitis
- For maintenance of healing of erosive esophagitis
- In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
- Zollinger-Ellison Syndrome
- Acid related Dyspepsia
- Duodenal & Gastric ulcer
Pharmacology
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
Storage Conditions
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.